Urinary tract infections (UTIs), including cystitis and pyelonephritis, are common. Each year, they account for more than 10 million outpatient visits and more than 3 million emergency department ...

UTI guidelines are moving away from complicated or uncomplicated infections to localized or systemic classification ...

The IDSA's first-ever complicated UTI guideline redefines the condition around systemic risk factors and severity, reflecting two decades of shifting resistance patterns, expanding indications, and ...

Cefepime-taniborbactam was 22% more effective than meropenem, which is a current treatment for complicated urinary tract infections (UTIs) and acute pyelonephritis, according to a study published in ...

Antibiotics. There is consensus that antibiotics are likely to be beneficial compared with placebo. Placebo-controlled trials of antibiotics for treating children with symptomatic acute urinary tract ...

Exblifep is a combination product that consists of cefepime, a cephalosporin antibacterial, and enmetazobactam, a beta-lactamase inhibitor. The Food and Drug Administration (FDA) has approved Exblifep ...

Infections in the lower urinary tract rarely migrate to the kidneys, but the precise mechanism that the human body employs to keep the twin organs disease-free has remained a medical mystery—until now ...

Clinical quiz - work through the questions to refresh your knowledge on safe, evidence-based care for women presenting with ...

A retrospective study at a Montreal pediatric emergency department found that about one in five antibiotic prescriptions for ...